Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4

Retraction of ‘Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4’ by Pengwei Lu et al., RSC Adv., 2018, 8, 8455–8468, DOI: 10.1039/C8RA00296G

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694806/
https://www.ncbi.nlm.nih.gov/pubmed/35427065
http://dx.doi.org/10.1039/d1ra90067f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694806/
https://www.ncbi.nlm.nih.gov/pubmed/35427065
http://dx.doi.org/10.1039/d1ra90067f

Ejemplares similares